Crossmark

Investigation of association between clinically significant prostate cancer, obesity and platelet to-lymphocyte ratio and neutrophil -to-lymphocyte ratio

Crossref DOI link: https://doi.org/10.1186/s12894-024-01617-2

Published Online: 2024-10-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dahan, Johanna

Pinthus, Jehonathan

Delouya, Guila

Taussky, Daniel

Duceppe, Emmanuelle

de Jesus, Amanda

Leong, Darryl
License Information

Text and Data Mining valid from 2024-10-16

Version of Record valid from 2024-10-16
More Information

Article History

Received: 19 June 2024

Accepted: 3 October 2024

First Online: 16 October 2024

Declarations

:

: This specific study was reviewed and approved by the Hamilton Integrated Research Ethics Board (CTO-0743 Ontario, Canada) before the study began. Written consent was obtained by all participants. All RADICAL-PC participants provided written informed consent.

: Not applicable.

: ED is supported by a clinician-scientist Junior 1 award from the Fonds de Recherche du Québec Santé and reports research grants for investigator-initiated research from Roche Diagnostics and Abbott Laboratories, both not related to this study. All other authors declare that they have no competing interests.

Document is current

Any future updates will be listed below